BCL2 and melanoma: Since higher concentrations of fisetin induced apoptosis in melanoma cells (Figure 1D), we next examined the effects of fisetin in combination with sorafenib at lower concentrations on activation of caspase-3, cleavage of PARP and expression of Bcl2 family proteins in melanoma cells.